Papaveretum

Papaveretum Chemische Eigenschaften,Einsatz,Produktion Methoden

• Clinical Use

  Opiate analgesia (15.4 mg/mL) 1 mL contains 10 mg anhydrous morphine, 1.2 mg papaverine HCl, and 1.04 mg codeine HCl

• Arzneimittelwechselwirkung

  Potentially hazardous interactions with other drugs
  Analgesics: possible opioid withdrawal with buprenorphine and pentazocine.
  Anti-arrhythmics: delayed absorption of mexiletine.
  Antidepressants: possible CNS excitation or depression with MAOIs – avoid; possible CNS excitation or depression with moclobemide; increased sedative effects with tricyclics.
  Antihistamines: increased sedative effects with sedating antihistamines.
  Antipsychotics: enhanced hypotensive and sedative effects.
  Dopaminergics: avoid with selegiline.
  Nalmefene: avoid concomitant use.
  Sodium oxybate: enhanced effect of sodium oxybate – avoid.

• Stoffwechsel

  Papaverine: Mainly metabolised in the liver and excreted in the urine, almost entirely as glucuronide-conjugated phenolic metabolites.

Papaveretum Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(1)Suppliers